BR9610134A - Processo para tratar um mamífero infectado com um fungo e composição - Google Patents
Processo para tratar um mamífero infectado com um fungo e composiçãoInfo
- Publication number
- BR9610134A BR9610134A BR9610134A BR9610134A BR9610134A BR 9610134 A BR9610134 A BR 9610134A BR 9610134 A BR9610134 A BR 9610134A BR 9610134 A BR9610134 A BR 9610134A BR 9610134 A BR9610134 A BR 9610134A
- Authority
- BR
- Brazil
- Prior art keywords
- fungus
- treating
- composition
- mammal infected
- infected
- Prior art date
Links
- 241000233866 Fungi Species 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52028995A | 1995-08-28 | 1995-08-28 | |
| US08/697,706 US5789387A (en) | 1995-08-28 | 1996-08-27 | Methods and compositions for treating fungal infections in mammals |
| PCT/US1996/013916 WO1997007802A1 (en) | 1995-08-28 | 1996-08-28 | Methods and compositions for treating fungal infections in mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9610134A true BR9610134A (pt) | 1999-07-27 |
Family
ID=27060105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9610134A BR9610134A (pt) | 1995-08-28 | 1996-08-28 | Processo para tratar um mamífero infectado com um fungo e composição |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5789387A (enExample) |
| EP (1) | EP0850063A1 (enExample) |
| JP (1) | JP2001516332A (enExample) |
| KR (1) | KR19990044174A (enExample) |
| CN (1) | CN1256631A (enExample) |
| AU (1) | AU6906096A (enExample) |
| BR (1) | BR9610134A (enExample) |
| CA (1) | CA2230856A1 (enExample) |
| IL (1) | IL123498A0 (enExample) |
| WO (1) | WO1997007802A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI934891L (fi) * | 1991-05-06 | 1993-12-03 | Procter & Gamble | Kombinerade kalcium- och vitamin d-supplement |
| WO2012094360A2 (en) | 2011-01-04 | 2012-07-12 | Gordon Chiu | Biotherapeutics for the treatment of infectious diseases |
| EP3036542B1 (en) * | 2013-06-21 | 2021-02-17 | Imigene Inc. | A method for assaying a blood sample obtained from a subject |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2928137A1 (de) * | 1979-07-12 | 1981-02-05 | Bayer Ag | Neue nikkomycine, ein verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel |
| DE3020722A1 (de) * | 1980-05-31 | 1981-12-10 | Bayer Ag, 5090 Leverkusen | Verfahren zur anreicherung von nikkomycin-gemischen |
| US4851389A (en) * | 1987-03-25 | 1989-07-25 | Miles Laboratories, Inc. | Use of nikkomycin compounds to treat infections of dimorphic, highly chitinous fungi |
| US5521153A (en) * | 1987-10-02 | 1996-05-28 | Ciba-Geigy Corporation | Synergistic antifungal protein and compositions containing same |
| US5194427A (en) * | 1987-11-09 | 1993-03-16 | Bayer Ag | Antimycotic compositions of nikkomycin compounds and azole antimycotics |
| ES2039273T3 (es) * | 1987-11-09 | 1993-09-16 | Bayer Ag | Compuestos antimicoticos a base de combinaciones de nicomicina y azol antimicotico. |
| US5006513A (en) * | 1987-11-09 | 1991-04-09 | Miles Inc. | Antimycotic compositions of nikkomycin compounds and azole antimycotica |
| US5134126A (en) * | 1987-11-09 | 1992-07-28 | Bayer Ag | Antimycotic compositions of nikkomycin compounds and azole antimycotics |
| US5096889A (en) * | 1987-11-09 | 1992-03-17 | Bayer Ag | Antimycotic compositions of nikkomycin compounds and azole antimycotics |
| US4914087A (en) * | 1988-02-29 | 1990-04-03 | Bayer Ag | Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
| US5091375A (en) * | 1988-02-29 | 1992-02-25 | Bayer Ag | Nikkomycin derivatives |
| US5149795A (en) * | 1988-10-03 | 1992-09-22 | Bayer Ag | Nikkomycin derivatives |
| US5019560A (en) * | 1988-10-03 | 1991-05-28 | Bayer Ag | Method for treating fungal infections with nikkomycin derivatives |
| JPH05502168A (ja) * | 1990-06-07 | 1993-04-22 | シンヘンタ モーヘン ベースローテン フェンノートシャップ | 新規な抗菌調製物、該調製物の製造方法および菌類耐性の大きい植物の作製方法 |
| US5326561A (en) * | 1992-12-15 | 1994-07-05 | Cornell Research Foundation, Inc. | Antifungal synergistic combination of enzyme fungicide and non-enzymatic fungicide and use thereof |
| US5238926A (en) * | 1991-08-20 | 1993-08-24 | Schering Corporation | Anti-fungal agents |
| US5236900A (en) * | 1991-08-20 | 1993-08-17 | Schering Corporation | Anti-fungal agents |
| US5346898A (en) * | 1992-06-18 | 1994-09-13 | Schering Corporation | Anti-fungal uracil compounds |
| US5229123A (en) * | 1991-10-09 | 1993-07-20 | Hoffmann-La Roche Inc. | Antifungal agents |
| US5614377A (en) * | 1994-02-28 | 1997-03-25 | Myco Pharmaceuticals, Incorporated | Methods for identifying inhibitors of fungal pathogenicity |
-
1996
- 1996-08-27 US US08/697,706 patent/US5789387A/en not_active Expired - Lifetime
- 1996-08-28 CA CA002230856A patent/CA2230856A1/en not_active Abandoned
- 1996-08-28 WO PCT/US1996/013916 patent/WO1997007802A1/en not_active Ceased
- 1996-08-28 CN CN96197725A patent/CN1256631A/zh active Pending
- 1996-08-28 KR KR1019980701408A patent/KR19990044174A/ko not_active Ceased
- 1996-08-28 JP JP51057697A patent/JP2001516332A/ja not_active Ceased
- 1996-08-28 BR BR9610134A patent/BR9610134A/pt not_active Application Discontinuation
- 1996-08-28 IL IL12349896A patent/IL123498A0/xx unknown
- 1996-08-28 EP EP96929794A patent/EP0850063A1/en not_active Withdrawn
- 1996-08-28 AU AU69060/96A patent/AU6906096A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0850063A1 (en) | 1998-07-01 |
| CA2230856A1 (en) | 1997-03-06 |
| US5789387A (en) | 1998-08-04 |
| JP2001516332A (ja) | 2001-09-25 |
| EP0850063A4 (enExample) | 1998-08-05 |
| KR19990044174A (ko) | 1999-06-25 |
| IL123498A0 (en) | 1998-09-24 |
| CN1256631A (zh) | 2000-06-14 |
| MX9801538A (es) | 1998-05-31 |
| WO1997007802A1 (en) | 1997-03-06 |
| AU6906096A (en) | 1997-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9408037A (pt) | Composição de branqueamento e processo para branquear um substrato manchado | |
| BR9408038A (pt) | Composição de branqueamento e processo para branquear um substrato manchado | |
| BR9408039A (pt) | Composição de branqueamento e processo para branquear um substrato manchado | |
| BR9602520A (pt) | Processo para controlar chamadas | |
| BR9707655A (pt) | Processo aperfeiçoada para a polimerização via radical livre e composição | |
| BR9407049A (pt) | Processo para tratar uma superficie | |
| BR9610574A (pt) | Composição e processo para controlar fungos nocivos | |
| BR9504561A (pt) | Processo de fabricaçao de restriçao e restriçao | |
| BR8906677A (pt) | Processo de montagem de um elevador e elevador obtido | |
| BR9507569A (pt) | Aparelho e processo de revestimento com matriz | |
| BR9801680A (pt) | Agente inibidor de incrustação e processo para usar o mesmo | |
| BR9609084A (pt) | Um processo para o tratamento de madeira com bactérias | |
| BR9100046A (pt) | Derivados de azaoxindole,composicao farmaceutica e processo para o tratamento de mamiferos | |
| BR8907264A (pt) | Composicao e processo de revestimento de composicao | |
| BR9708881A (pt) | Composição alvejante processo para alvejar um substrato manchado e alvejante | |
| BR9510644A (pt) | Composiç o curável e processo | |
| BR9005602A (pt) | Processo para tratamento de componente ferroso para subsequente ligacao com aluminio fundido | |
| BR9612281A (pt) | Processo para preparação de um 1,2-bis(aciloóxilato) e de um 3,4-diacetóxi-1-buteno | |
| BR9706635A (pt) | Processo para aplicação de um revestimento para vidro plano e vidro resultante | |
| BR9610700A (pt) | Composição e processo para controlar fungos nocivos | |
| BR9408115A (pt) | Processo para funcionalização de um polímero e polímero obtido | |
| BR9405273A (pt) | Fio polifilamentado,dificilmente inflamável,processo para sua fabricação e sua aplicação | |
| BR9405666A (pt) | Processo para secagem de filamentos de madeira | |
| BR9507567A (pt) | Dispositivo e processo de revestimento por matriz | |
| BR9004609A (pt) | Processo para tratamento de um arame de aco revestido com latao e arame de aco revestido com latao |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |